Reshape Lifesciences Inc share price logo

Reshape Lifesciences Inc Share Price

NASDAQ: HIND

Small Cap

$2.19

+0.08

(+3.79%)

as on

Reshape Lifesciences Inc Stock Performance

as on April 9, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.16
    $2.25
    downward going graph

    1.37%

    Downside

    2.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.75
    $16.00
    downward going graph

    20.09%

    Downside

    630.59%

    Upside

    downward going graph

Reshape Lifesciences Inc share price movements today

Previous Close
$2.11
Open
$2.19
Volume
144.0K
Day's Low - High
$2.16 - $2.25
52 Week Low - High
$1.75 - $16.00

Reshape Lifesciences Inc Historical Returns

1 Month Return
-24.64 %
3 Month Return
-38.48 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Reshape Lifesciences Inc Stock Fundamentals & Key Indicators

Check Reshape Lifesciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.2M

EPS (TTM)

-0.78

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Reshape Lifesciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Reshape Lifesciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Reshape Lifesciences Inc image
Reshape Lifesciences Inc
NA$15.2MNANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$35.2B404.42%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.8B124.22%141.788.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.3B105.37%28.3732.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.7B59.6%18.4131.41%

Reshape Lifesciences Inc Stock’s Investor Sentiment and Interest

Search interest for Reshape Lifesciences Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Reshape Lifesciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
1
1
2
0
1
1
0
0
Gross Profit
1
1
1
1
1
0
0
0
0
0
Operating Income
-3
-3
-2
-2
-1
0
-2
-2
-8
-1
EBITDA
-3
-3
-2
-2
-1
-
-1
-2
-8
10
Interest Expense
-
-
-
-
0
0
0
0
0
0
Depreciation
-
-
-
-
0
0
-
-
0
0
Income Before Tax
-3
-3
-2
-1
-1
0
1
-2
-8
-1
Income Tax Expense
0
0
0
0
0
-
0
0
-
0
Net Income
-3
-3
-2
-1
-1
0
1
-2
-8
-1
Net Profit Margin
-154.97%
-163.99%
-112.81%
-81.17%
-68.98%
-499.05%
132.43%
-211.76%
-24822.54%
-3352.75%

Reshape Lifesciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
0
15
11
13
11
8
8
0
Gross Profit
0
0
0
9
6
8
6
5
5
0
Operating Income
-22
-31
-38
-24
-12
-57
-27
-14
-7
-2
EBITDA
-19
-34
-36
-72
-18
-60
-44
-11
-6
-2
Interest Expense
4
0
0
0
2
0
0
0
0
0
Depreciation
-
-
-
-
-
-
0
0
0
0
Income Before Tax
-23
-36
-38
-75
-21
-63
-46
-11
-7
-10
Income Tax Expense
-
-2
-3
0
0
0
0
0
0
-
Net Income
-23
-33
-81
-74
-21
-63
-46
-11
-7
-10
Net Profit Margin
-2969.62%
-2627.34%
-13375.68%
-491.80%
-191.43%
-464.31%
-411.16%
-131.22%
-89.06%
-3209.75%

Reshape Lifesciences Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
-2
-1
-1
0
1
-2
-8
10
Operating Cash Flow
-2
-2
-1
0
0
-2
-4
4
-1
Investing Cash Flow
-
3
-
-
-
4
10
-15
20
Financing Cash Flow
0
5
0
0
0
3
6
-2
0
Change in Cash
-3
-2
-1
0
0
1
1
1
0

Reshape Lifesciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-35
-74
-21
-35
-46
-11
-7
-10
Operating Cash Flow
-24
-27
-14
-8
-15
-21
-16
-4
-3
Investing Cash Flow
-6
-10
-2
-2
1
0
0
-
-
Financing Cash Flow
37
33
13
11
33
3
17
0
8
Change in Cash
6
-4
-2
-11
19
-18
0
-3
4

Insights on Reshape Lifesciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -8.59M → -1.22M (in $), with an average increase of 601.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 34.62K → 36.55K (in $), with an average increase of 5.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 141.3% return, outperforming this stock by 216.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 868.7% return, outperforming this stock by 968.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, HIND stock has moved down by -75.3%

About Reshape Lifesciences Inc

Vyome Holdings, Inc. is a clinical-stage healthcare holding company. The Company is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
OrganisationReshape Lifesciences Inc
HeadquartersHarvard Square, Cambridge, MA, United States, 02138
CEOMr. Venkateswarlu Nelabhotla M.B.A.
E-voting on sharesClick here to vote

Key Management of Reshape Lifesciences Inc

Name

Title

Mr. Robert Dickey IV

Chief Financial Officer

Dr. Richard Fahrner Ph.D.

Chief Technology Officer

Dr. Charles G. Chavdarian Ph.D.

Senior Vice President of Product Development & Regulatory CMC

Dr. Tamara Agajanov M.D.

Senior Vice President of Clinical Development

Mr. Venkateswarlu Nelabhotla M.B.A.

Co-Founder, CEO, President & Director

Dr. Shiladitya Sengupta M.Sc., Ph.D.

Co-Founder, Director and Member of Scientific & Clinical Advisory Board

FAQs

What is Reshape Lifesciences Inc share price today?

Reshape Lifesciences Inc share price today is $2.19 as on at the close of the market. Reshape Lifesciences Inc share today touched a day high of $2.25 and a low of $2.16.

What is the 52 week high and 52 week low for Reshape Lifesciences Inc share?

Reshape Lifesciences Inc share touched a 52 week high of $16 on and a 52 week low of $1.75 on . Reshape Lifesciences Inc stock price today i.e. is closed at $2.19,which is 86.31% down from its 52 week high and 25.14% up from its 52 week low.

What is Reshape Lifesciences Inc's market capitalisation today?

Reshape Lifesciences Inc market capitalisation is $0.00T as on .

How to invest in Reshape Lifesciences Inc Stock (HIND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Reshape Lifesciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Reshape Lifesciences Inc Shares that will get you 0.6849 shares as per Reshape Lifesciences Inc share price of $2.19 per share as on April 9, 2026 at 1:29 am IST.

What is the minimum amount required to buy Reshape Lifesciences Inc Stock (HIND) from India?

Indian investors can start investing in Reshape Lifesciences Inc (HIND) shares with as little as ₹92.336 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.36 in Reshape Lifesciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Reshape Lifesciences Inc share’s latest price of $2.19 as on April 9, 2026 at 1:29 am IST, you will get 4.5662 shares of Reshape Lifesciences Inc. Learn more about fractional shares .